LifeBond

Since 2007 / Life Sciences

www.life-bond.com

CEO

Gideon Sturlesi  

NEWS

LifeBond Receives FDA IDE Approval For LifeSeal GI Surcial Sealant Clinical Trial

Read More >

Lifebond Closes $27M Series D Financing Round

Read More >

Board Member

Ittai Harel


LifeBond is developing a line of biosurgical products for prevention of surgical leakage and bleeding.